|
|
||||||||
to Elaborate TGF-
-Based Suppression1



* Division of Immunology, University of Connecticut Health Center, Farmington, CT 06032;
Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92121;
Immunomodulation Research Center, University of Ulsan, Ulsan, Republic of Korea; and
Department of Surgery, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329
We identified a murine peptide-specific CD8 T regulatory cell population able to suppress responding CD4 T cells. Immunization with OVA, poly(I:C), and anti-4-1BB generated a population of SIINFEKL-specific CD8 T regulatory cells that profoundly inhibited peptide-responding CD4 T cells from cellular division. The mechanism of suppression required IFN-
, but IFN-
alone was not sufficient to suppress the responding CD4 T cells. The data show that CD8 T regulatory cells were unable to suppress unless they engaged IFN-
. Furthermore, even in the absence of recall with peptide, the CD8 T regulatory cells suppressed CD4 responses as long as IFN-
was present. To examine the effector mechanism of suppression, we showed that neutralizing TGF-
inhibited suppression because inclusion of anti-TGF-
rescued the proliferative capacity of the responding cells. TGF-
-based suppression was dependent completely upon the CD8 T regulatory cells being capable of binding IFN-
. This was the case, although peptide recall of primed IFN-
/ or IFN-
R/ CD8 T cells up-regulated pro-TGF-
protein as measured by surface latency-associated peptide expression but yet were unable to suppress. Finally, we asked whether the CD8 T regulatory cells were exposed to active TGF-
in vivo and showed that only wild-type CD8 T regulatory cells expressed the TGF-
-dependent biomarker CD103, suggesting that latency-associated peptide expression is not always congruent with elaboration of active TGF-
. These data define a novel mechanism whereby IFN-
directly stimulates CD8 T regulatory cells to elaborate TGF-
-based suppression. Ultimately, this mechanism may permit regulation of pathogenic Th1 responses by CD8 T regulatory cells.
This article has been cited by other articles:
![]() |
Y. H. Kim, B. K. Choi, W. J. Kang, K. H. Kim, S. W. Kang, A. L. Mellor, D. H. Munn, and B. S. Kwon IFN-{gamma}-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo J. Leukoc. Biol., May 1, 2009; 85(5): 817 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Prado, E. G. Marazuela, E. Segura, H. Fernandez-Garcia, M. Villalba, C. Thery, R. Rodriguez, and E. Batanero Exosomes from Bronchoalveolar Fluid of Tolerized Mice Prevent Allergic Reaction J. Immunol., July 15, 2008; 181(2): 1519 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chattopadhyay, J. O'Rourke, and R. E. Cone Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells Int. Immunol., April 1, 2008; 20(4): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ho, C. C. Kurtz, M. Naganuma, P. B. Ernst, F. Cominelli, and J. Rivera-Nieves A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis J. Immunol., February 15, 2008; 180(4): 2573 - 2580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Lee, R. J. Rossi, S.-K. Lee, M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent J. Immunol., August 15, 2007; 179(4): 2203 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Billerbeck, H. E. Blum, and R. Thimme Parallel Expansion of Human Virus-Specific FoxP3- Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro J. Immunol., July 15, 2007; 179(2): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Niu, S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, et al. Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice J. Immunol., April 1, 2007; 178(7): 4194 - 4213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Menoret, L. M. Myers, S.-J. Lee, R. S. Mittler, R. J. Rossi, and A. T. Vella TGFbeta Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells J. Immunol., November 1, 2006; 177(9): 6091 - 6097. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bitsaktsis and G. Winslow Fatal Recall Responses Mediated by CD8 T cells during Intracellular Bacterial Challenge Infection J. Immunol., October 1, 2006; 177(7): 4644 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Uss, A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. W. van Lier, and I. J. M. ten Berge CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells. J. Immunol., September 1, 2006; 177(5): 2775 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Cheng, H.-W. Chen, J.-P. Tsai, Y.-P. Lee, Y.-C. Shih, C.-M. Chang, and C.-C. Ting Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta} J. Leukoc. Biol., May 1, 2006; 79(5): 1033 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Degauque, D. Lair, A. Dupont, A. Moreau, G. Roussey, F. Moizant, F. X. Hubert, C. Louvet, M. Hill, F. Haspot, et al. Dominant Tolerance to Kidney Allografts Induced by Anti-Donor MHC Class II Antibodies: Cooperation between T and Non-T CD103+ Cells J. Immunol., April 1, 2006; 176(7): 3915 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vidric, W.-K. Suh, U. Dianzani, T. W. Mak, and T. H. Watts Cooperation between 4-1BB and ICOS in the Immune Response to Influenza Virus Revealed by Studies of CD28/ICOS-Deficient Mice J. Immunol., December 1, 2005; 175(11): 7288 - 7296. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-K. Park, L. D. Shultz, J. J. Letterio, and J. D. Gorham TGF-{beta}1 Inhibits T-bet Induction by IFN-{gamma} in Murine CD4+ T Cells through the Protein Tyrosine Phosphatase Src Homology Region 2 Domain-Containing Phosphatase-1 J. Immunol., November 1, 2005; 175(9): 5666 - 5674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |